516 related articles for article (PubMed ID: 17325179)
1. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
[TBL] [Abstract][Full Text] [Related]
2. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.
Aleman TS; Duncan JL; Bieber ML; de Castro E; Marks DA; Gardner LM; Steinberg JD; Cideciyan AV; Maguire MG; Jacobson SG
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1873-81. PubMed ID: 11431456
[TBL] [Abstract][Full Text] [Related]
3. Spatial profile of macular pigment and its relationship to foveal architecture.
Nolan JM; Stringham JM; Beatty S; Snodderly DM
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
6. The relationship of macular pigment optical density to serum lutein in retinitis pigmentosa.
Sandberg MA; Johnson EJ; Berson EL
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1086-91. PubMed ID: 19797209
[TBL] [Abstract][Full Text] [Related]
7. Macular pigment optical density relates to foveal thickness.
van der Veen RL; Ostendorf S; Hendrikse F; Berendschot TT
Eur J Ophthalmol; 2009; 19(5):836-41. PubMed ID: 19787606
[TBL] [Abstract][Full Text] [Related]
8. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
9. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population.
Curran-Celentano J; Hammond BR; Ciulla TA; Cooper DA; Pratt LM; Danis RB
Am J Clin Nutr; 2001 Dec; 74(6):796-802. PubMed ID: 11722962
[TBL] [Abstract][Full Text] [Related]
10. Central serous chorioretinopathy produces macular pigment profile changes.
Putnam CM; Kinerk WT; Bassi CJ
Optom Vis Sci; 2013 Jul; 90(7):e206-12. PubMed ID: 23770658
[TBL] [Abstract][Full Text] [Related]
11. The use of heterochromatic flicker photometry to determine macular pigment optical density in a healthy Australian population.
Abell RG; Hewitt AW; Andric M; Allen PL; Verma N
Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):417-21. PubMed ID: 24390399
[TBL] [Abstract][Full Text] [Related]
12. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
13. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
15. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
[TBL] [Abstract][Full Text] [Related]
16. Candidate gene study of macular response to supplemental lutein and zeaxanthin.
Yonova-Doing E; Hysi PG; Venturini C; Williams KM; Nag A; Beatty S; Liew SH; Gilbert CE; Hammond CJ
Exp Eye Res; 2013 Oct; 115():172-7. PubMed ID: 23891863
[TBL] [Abstract][Full Text] [Related]
17. Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.
Nolan JM; Kenny R; O'Regan C; Cronin H; Loughman J; Connolly EE; Kearney P; Loane E; Beatty S
Ophthalmic Res; 2010; 44(2):131-9. PubMed ID: 20516725
[TBL] [Abstract][Full Text] [Related]
18. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
[TBL] [Abstract][Full Text] [Related]
19. The association of retinal structure and macular pigment distribution.
Meyer zu Westrup V; Dietzel M; Pauleikhoff D; Hense HW
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1169-75. PubMed ID: 24474270
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
